2008至2018年丹麦先天性心脏缺陷病例中染色体异常的患病率:基于登记的研究
该研究基于丹麦国家登记数据,纳入2008年7月至2018年12月期间所有单胎、产前或产后诊断的重大先天性心脏缺陷(CHD)病例,共1449例,其中918例(63.4%)接受了染色体分析。结果发现重大CHD病例中染色体异常的总患病率为12.9%(95%CI 11.2-14.7%),不同CHD亚型间差异显著,非孤立性病例的OR为2.72(95%CI 1.90-3.88)。
要点
- 重大CHD病例中染色体异常总患病率为12.9%(95%CI 11.2-14.7%)。
- 非孤立性病例较孤立性病例的染色体异常OR为2.72(95%CI 1.90-3.88)。
- 肺动脉闭锁伴室间隔完整及共同动脉干患病率最高(均28.6%),完全性大动脉转位最低(2.2%)。
核心结论
- 在筛查参与率高的国家队列中,重大CHD病例的染色体异常总患病率为12.9%,且随CHD诊断及是否合并心外畸形而显著变化,对产前咨询有重要意义。
研究设计与样本
- 基于丹麦胎儿医学数据库和丹麦细胞遗传学中央登记处的全国登记研究,纳入2008年7月至2018年12月所有单胎重大CHD病例1449例,染色体分析包括核型分析、染色体微阵列、聚合酶链反应、多重连接依赖探针扩增和荧光原位杂交。
诊断标准与关键数值
- 致病性和可能致病性变异视为异常;未登记染色体分析者视为遗传学正常;孤立性CHD定义为无其他结构畸形。
临床应用与阅片要点
- 不同CHD亚型的染色体异常患病率差异显著,完全性大动脉转位孤立性病例患病率仅0.6%,非孤立性病例患病风险约为孤立性病例的2.72倍(95%CI 1.90-3.88)。
局限性
- 未采用全基因组和全外显子组测序。
- 未登记染色体分析的病例被视为遗传学正常。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To estimate the prevalence of chromosomal conditions in all fetuses and children with major congenital heart defect (CHD) in Denmark between 2008 and 2018.
METHODS: This was a national registry-based study including all singleton pregnancies with a prenatally or postnatally diagnosed major CHD usually requiring surgery within the first year after birth and a due date between July 2008 and December 2018 in Denmark. Data were retrieved from the Danish Fetal Medicine Database (DFMD) and the Danish Cytogenetic Central Register (DCCR) in October 2020. The DCCR contains information on all prenatal and postnatal genetic analyses, including karyotyping, chromosomal microarray, polymerase chain reaction, multiplex ligation-dependent probe amplification and fluorescence in-situ hybridization. All cases were reviewed by a clinical geneticist, and genetic changes were classified as pathogenic, likely pathogenic, variant of uncertain significance, likely benign or benign. Pathogenic and likely pathogenic variants were considered to be abnormal. Cases with CHD without any registered chromosomal analysis reported were considered genetically normal. Isolated CHD was defined as a case with major CHD without any other structural malformations detected prenatally or postnatally. Results are given as n (%). Comparisons between isolated and non-isolated cases were performed using logistic regression analysis, and data are presented as odds ratios (ORs) with 95% CIs.
RESULTS: A total of 8482 cases with any cardiovascular diagnosis were retrieved from the DFMD. Twins (n = 112) and minor CHD cases (n = 6921) were excluded, resulting in 1449 cases with major CHD. Of the included cases, 918 (63.4%) underwent chromosomal analysis. An abnormal test result was found in 187 cases, giving a prevalence of a chromosomal condition of 12.9% (95% CI, 11.2-14.7%) among all cases with major CHD. The highest prevalence of a chromosomal condition was found in cases with pulmonary atresia with intact ventricular septum and those with truncus arteriosus (both 28.6%), while the lowest prevalence was found in cases with transposition of the great arteries (2.2%) and congenitally corrected transposition of the great arteries (0%). In isolated cases of transposition of the great arteries, the prevalence of a chromosomal condition was 0.6%. The overall OR for a chromosomal condition in non-isolated cases compared with isolated cases was 2.72 (95% CI, 1.90-3.88).
CONCLUSIONS: We found an overall prevalence of a chromosomal condition of 12.9% among cases with major CHD in a national cohort with a high participation rate in first- and second-trimester screening, without employing whole genome and whole exome sequencing. The prevalence of a chromosomal condition varied considerably according to CHD diagnosis and presence of associated extracardiac malformations. These findings are important for prenatal counseling. © 2022 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Vedel C, Hjortshøj TD, Jørgensen DS, et al. Prevalence of chromosomal disorders in cases with congenital heart defect: registry-based study from Denmark between 2008 and 2018. Ultrasound Obstet Gynecol. 2023. PMID: 36099538. doi:10.1002/uog.26075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。